Gyre Therapeutics (GYRE) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -364.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -364.01% |
| Dec 31, 2025 | 2.09% |
| Sep 30, 2025 | 107.84% |
| Jun 30, 2025 | -65.27% |
| Mar 31, 2025 | -62.42% |
| Dec 31, 2024 | 78.77% |
| Sep 30, 2024 | -61.97% |
| Jun 30, 2024 | 20.37% |
| Mar 31, 2024 | 135.59% |
| Dec 31, 2023 | -261.95% |
| Sep 30, 2023 | 253.77% |
| Jun 30, 2023 | -92.70% |
| Mar 31, 2023 | 129.01% |
| Dec 31, 2022 | -37.37% |
| Sep 30, 2022 | 80.64% |
| Jun 30, 2022 | 359.42% |
| Mar 31, 2022 | 35.17% |
| Dec 31, 2021 | -3.90% |
| Sep 30, 2021 | -57.31% |
| Jun 30, 2021 | -15.39% |
| Mar 31, 2021 | -373.62% |
| Dec 31, 2020 | -44.46% |
| Sep 30, 2020 | -26.18% |
| Jun 30, 2020 | -25.17% |
| Mar 31, 2020 | 68.61% |
| Dec 31, 2019 | -2.35% |
| Sep 30, 2019 | -65.16% |
| Jun 30, 2019 | -111.61% |
| Mar 31, 2019 | -199.15% |
| Dec 31, 2018 | -121.65% |
| Sep 30, 2018 | -32.80% |
| Jun 30, 2018 | -10.54% |
| Mar 31, 2018 | -21.85% |
| Dec 31, 2017 | -59.04% |
| Sep 30, 2017 | -21.42% |
| Jun 30, 2017 | -21.89% |
| Mar 31, 2017 | -15.20% |
| Dec 31, 2016 | 42.37% |
| Sep 30, 2016 | -32.09% |
| Jun 30, 2016 | -11.46% |
| Mar 31, 2016 | 46.80% |
| Dec 31, 2015 | -42.82% |
| Sep 30, 2015 | 25.68% |
| Jun 30, 2015 | 46.71% |
| Mar 31, 2015 | 54.98% |
| Dec 31, 2014 | 65.90% |
| Sep 30, 2014 | 62.33% |
| Jun 30, 2014 | 34.23% |
| Mar 31, 2014 | -85.95% |
| Dec 31, 2013 | 16.64% |
| Sep 30, 2013 | -63.75% |
| Jun 30, 2013 | -185.36% |
| Mar 31, 2013 | -457.06% |
| Dec 31, 2012 | -63.45% |
| Sep 30, 2012 | 12.98% |
| Jun 30, 2012 | 742.09% |
| Mar 31, 2012 | -82.05% |
| Dec 31, 2011 | -353.10% |
| Sep 30, 2011 | -464.20% |
| Jun 30, 2011 | -159.68% |